论文部分内容阅读
上市公司的行为和表现,更多的被社会所关注;再加上此次空前的大牛市背景,几家兽药生物制品企业就显得更加扎眼。刚刚过去的这个夏天,国内兽药疫苗生产企业格外热闹,先是有金宇集团(证券代码:600201)控股扬州优邦生物制药有限公司,之后爆出华兰生物(证券代码:002007)出场与金宇竞购扬州威克生物工程有限公司。华兰生物的半道杀出,使得扬州威克生物工程花落谁家变得扑朔迷离。更加富有戏剧性和张力的疫苗企业争夺事件还在后头:2007年8月27日,宁波天邦股份有限公司向南京市中级人民法院提起诉讼,请求法院判定公司有权回购被告方在南京天邦所持有的50%股权,并将涉诉股权判归公司所有。自此,之前传出的中牧股份欲收购南京天邦生物科技有限公司,以及中牧股份之前与南京天邦股东江苏省农科院达成的一系列合作协议,在宁波天邦的强势回购南京天邦的架势面前,让人欲说还休。疫苗生产企业在诸多竞购事件的背景下,显得引人注目,与之前众多生物制品企业连连哀叹的声音迥然二致,其间的台前内幕到底如何?
The behavior and performance of listed companies, more by the community’s attention; coupled with the unprecedented bull market background, several veterinary drugs biotech enterprises become even more eye-catching. This summer just past, the domestic veterinary vaccine manufacturers particularly lively, first with the Jinyu Group (stock code: 600201) holding Yangzhou Yobo Biological Pharmaceutical Co., Ltd., then broke Hualan (stock code: 002007) played with Jinyu bid Yangzhou Wacker Biological Engineering Co., Ltd. Hualan biological halfway out, making the Yangzhou Wacker biological engineering who became confusing. On August 27, 2007, Ningbo Tianbang Co., Ltd. filed a lawsuit with Nanjing Intermediate People’s Court requesting the court to determine that the company has the right to repurchase the defendant in Nanjing Tian Bang Held by the 50% stake, and will tell the equity ownership of the company. Since then, China Animal Husbandry shares came forward to buy Nanjing Tianbang Biotechnology Co., Ltd., and animal husbandry before shares with Nanjing Tianbang Jiangsu Provincial Academy of Agricultural Sciences reached a series of cooperation agreements in Ningbo Tianbang strong repurchase Nanjing days In front of the state posture, people want to say rest. Vaccine manufacturers in the context of many bidding events, it is compelling, and many biologists lamenting the company after another very different voice, in the meantime what the hell of the insider?